Literature DB >> 32649075

Remdesivir for the Treatment of Covid-19 - Preliminary Report.

James H McMahon1, Andrew Udy1, Anton Y Peleg1.   

Abstract

Entities:  

Year:  2020        PMID： 32649075     DOI： 10.1056/NEJMc2022236

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

Review 1.  Zinc supplementation as an adjunct therapy for COVID-19: Challenges and opportunities.

Authors:  Vidyasagar Chinni; John El-Khoury; Marlon Perera; Rinaldo Bellomo; Daryl Jones; Damien Bolton; Joseph Ischia; Oneel Patel
Journal:  Br J Clin Pharmacol       Date:  2021-06-02       Impact factor: 3.716

Review 2.  COVID-19 Clinical Trials Registered Worldwide for Drug Intervention: An Overview and Characteristic Analysis.

Authors:  Bin Wang; Junkai Lai; Xiaoyan Yan; Feifei Jin; Bin Yi; Caixia An; Yuanxiao Li; Chen Yao
Journal:  Drug Des Devel Ther       Date:  2020-11-19       Impact factor: 4.162

3.  Clinical characteristics and outcome of hospitalized patients with SARS-CoV-2 infection at Toulouse University hospital (France). Results from the Covid-clinic-Toul cohort.

Authors:  A Jourdes; M Lafaurie; G Martin-Blondel; P Delobel; M Faruch; S Charpentier; V Minville; S Silva; C Thalamas; A Sommet; G Moulis
Journal:  Rev Med Interne       Date:  2020-10-07       Impact factor: 0.728

Review 4.  COVID-19 update: The race to therapeutic development.

Authors:  Julianne D Twomey; Shen Luo; Alexis Q Dean; William P Bozza; Ancy Nalli; Baolin Zhang
Journal:  Drug Resist Updat       Date:  2020-10-24       Impact factor: 18.500

5.  Innate lymphoid cell composition associates with COVID-19 disease severity.

Authors:  Marina García; Efthymia Kokkinou; Anna Carrasco García; Tiphaine Parrot; Laura M Palma Medina; Kimia T Maleki; Wanda Christ; Renata Varnaitė; Iva Filipovic; Hans-Gustaf Ljunggren; Niklas K Björkström; Elin Folkesson; Olav Rooyackers; Lars I Eriksson; Anders Sönnerborg; Soo Aleman; Kristoffer Strålin; Sara Gredmark-Russ; Jonas Klingström; Jenny Mjösberg
Journal:  Clin Transl Immunology       Date:  2020-12-14

6.  Cost-effectiveness of Remdesivir and Dexamethasone for COVID-19 Treatment in South Africa.

Authors:  Youngji Jo; Lise Jamieson; Ijeoma Edoka; Lawrence Long; Sheetal Silal; Juliet R C Pulliam; Harry Moultrie; Ian Sanne; Gesine Meyer-Rath; Brooke E Nichols
Journal:  Open Forum Infect Dis       Date:  2021-01-29       Impact factor: 3.835

7.  Lung transplantation for patients with severe COVID-19.

Authors:  Ankit Bharat; Melissa Querrey; Nikolay S Markov; Samuel Kim; Chitaru Kurihara; Rafael Garza-Castillon; Adwaiy Manerikar; Ali Shilatifard; Rade Tomic; Yuliya Politanska; Hiam Abdala-Valencia; Anjana V Yeldandi; Jon W Lomasney; Alexander V Misharin; G R Scott Budinger
Journal:  Sci Transl Med       Date:  2020-11-30       Impact factor: 17.956

8.  Association between Functional Inhibitors of Acid Sphingomyelinase (FIASMAs) and Reduced Risk of Death in COVID-19 Patients: A Retrospective Cohort Study.

Authors:  Gil Darquennes; Pascal Le Corre; Olivier Le Moine; Gwenolé Loas
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-07

9.  Pharmacokinetics under the COVID-19 storm.

Authors:  Venkatesh Pilla Reddy; Eman El-Khateeb; Heeseung Jo; Natalie Giovino; Emily Lythgoe; Shringi Sharma; Weifeng Tang; Masoud Jamei; Amin Rastomi-Hodjegan
Journal:  Br J Clin Pharmacol       Date:  2020-11-23       Impact factor: 3.716

10.  Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report.

Authors:  Matthew S Buckland; James B Galloway; Caoimhe Nic Fhogartaigh; Luke Meredith; Nicholas M Provine; Stuart Bloor; Ane Ogbe; Wioleta M Zelek; Anna Smielewska; Anna Yakovleva; Tiffeney Mann; Laura Bergamaschi; Lorinda Turner; Frederica Mescia; Erik J M Toonen; Carl-Philipp Hackstein; Hossain Delowar Akther; Vinicius Adriano Vieira; Lourdes Ceron-Gutierrez; Jimstan Periselneris; Sorena Kiani-Alikhan; Sofia Grigoriadou; Devan Vaghela; Sara E Lear; M Estée Török; William L Hamilton; Joanne Stockton; Josh Quick; Peter Nelson; Michael Hunter; Tanya I Coulter; Lisa Devlin; John R Bradley; Kenneth G C Smith; Willem H Ouwehand; Lise Estcourt; Heli Harvala; David J Roberts; Ian B Wilkinson; Nick Screaton; Nicholas Loman; Rainer Doffinger; Paul A Lyons; B Paul Morgan; Ian G Goodfellow; Paul Klenerman; Paul J Lehner; Nicholas J Matheson; James E D Thaventhiran
Journal:  Nat Commun       Date:  2020-12-14       Impact factor: 17.694
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.